{"id":327691,"date":"2026-10-27T10:06:12","date_gmt":"2026-10-27T04:36:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=327691"},"modified":"2026-10-27T10:06:12","modified_gmt":"2026-10-27T04:36:12","slug":"largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap Stocks With PB Between 3 and 6 to Watch for Future Multibagger Potential: Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Infosys Rs 1,166. Sun Pharma Rs 1,740. UltraTech Cement Rs 11,180. Tech Mahindra Rs 1,795. Market caps from Rs 1.60 lakh crore to Rs 4.47 lakh crore. Data as of 26 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra are the 4 picks in this stocks with PB between 3 and 6 watchlist, with market caps between Rs 1.60 lakh crore and Rs 4.47 lakh crore. Infosys stands out for the highest return on equity at 33.24%, while Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. PE ratios run from 14.73 to 37.70, so compare each one with its industry PE before investing. All figures are as of 26 October 2026.<\/p>\n<\/p><\/div>\n<p>Stocks with PB between 3 and 6 to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra meet that test, with market caps from Rs 1.60 lakh crore to Rs 4.47 lakh crore and Infosys offering the highest return on equity at 33.24%. Each of these companies has a price to book ratio between 3 and 6, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a price to book ratio between 3 and 6, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks with PB between 3 and 6 usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 26 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=stocks-with-pb-between-and\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#What_Are_Stocks_With_PB_Between_3_and_6_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Stocks With PB Between 3 and 6 and Why Do They Attract Multibagger Interest?\">What Are Stocks With PB Between 3 and 6 and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Stocks_With_PB_Between_3_and_6_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Stocks With PB Between 3 and 6 at a Glance: Price, Market Cap, PE and ROE\">Stocks With PB Between 3 and 6 at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Infosys_Return_on_Equity_of_3324\" title=\"Infosys: Return on Equity of 33.24%\">Infosys: Return on Equity of 33.24%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#UltraTech_Cement_Profit_Compounding_at_336_a_Year\" title=\"UltraTech Cement: Profit Compounding at 3.36% a Year\">UltraTech Cement: Profit Compounding at 3.36% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Tech_Mahindra_Debt-to-Equity_of_007\" title=\"Tech Mahindra: Debt-to-Equity of 0.07\">Tech Mahindra: Debt-to-Equity of 0.07<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Stocks_With_PB_Between_3_and_6_Financial_Comparison_on_Growth_and_Margins\" title=\"Stocks With PB Between 3 and 6: Financial Comparison on Growth and Margins\">Stocks With PB Between 3 and 6: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Institutional_Holding_in_Infosys_Sun_Pharma_UltraTech_Cement_and_Tech_Mahindra\" title=\"Institutional Holding in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra\">Institutional Holding in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Stocks_With_PB_Between_3_and_6\" title=\"Risks to Weigh in Stocks With PB Between 3 and 6\">Risks to Weigh in Stocks With PB Between 3 and 6<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#How_to_Choose_Between_Stocks_With_PB_Between_3_and_6\" title=\"How to Choose Between Stocks With PB Between 3 and 6\">How to Choose Between Stocks With PB Between 3 and 6<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Stocks_With_PB_Between_3_and_6_to_Watch\" title=\"Frequently Asked Questions on Stocks With PB Between 3 and 6 to Watch\">Frequently Asked Questions on Stocks With PB Between 3 and 6 to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Which_are_the_best_stocks_with_PB_between_3_and_6_to_watch_for_multibagger_potential\" title=\"Which are the best stocks with PB between 3 and 6 to watch for multibagger potential?\">Which are the best stocks with PB between 3 and 6 to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Is_Infosys_a_good_stock_for_long-term_investors\" title=\"Is Infosys a good stock for long-term investors?\">Is Infosys a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Infosys_Sun_Pharma_UltraTech_Cement_and_Tech_Mahindra\" title=\"What is the market cap of Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?\">What is the market cap of Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_stocks_with_PB_between_3_and_6\" title=\"What are the risks of investing in stocks with PB between 3 and 6?\">What are the risks of investing in stocks with PB between 3 and 6?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#Why_is_Tech_Mahindra_trading_at_a_PE_of_3097\" title=\"Why is Tech Mahindra trading at a PE of 30.97?\">Why is Tech Mahindra trading at a PE of 30.97?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-with-pb-between-3-and-6-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Infosys_Sun_Pharma_UltraTech_Cement_and_Tech_Mahindra\" title=\"How much do institutions hold in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?\">How much do institutions hold in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Stocks_With_PB_Between_3_and_6_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Stocks With PB Between 3 and 6 and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Stocks with PB between 3 and 6 are shares that trade at 3 to 6 times book value, a range usually earned by businesses that make healthy returns on the capital invested in them. The four here cover IT services, pharmaceuticals and cement.<\/p>\n<p>A price to book ratio in this range typically reflects a company that creates value well above its asset base. For stocks with PB between 3 and 6, both FY26 and the latest quarter showed growth. Whichever way you read stocks with PB between 3 and 6, the common thread is rising profit backed by complete financial data. For stocks with PB between 3 and 6, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of stocks with PB between 3 and 6, using FY26 and latest quarter data. Prices move daily, so recheck the figures for stocks with PB between 3 and 6 before you decide.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_With_PB_Between_3_and_6_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Stocks With PB Between 3 and 6 at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 26 October 2026. Infosys combines the lowest PE of the group, 14.73, with the highest return on equity, 33.24%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/infy\/infosys-ltd-share-price-today\">Infosys<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,166<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,46,753<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.73<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.27<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">33.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">980.40 to 1,728.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,740<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,18,102<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ultracemco\/ultratech-cement-ltd-share-price-today\">UltraTech Cement<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,180<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,23,092<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.41<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.66%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.31<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10,325.00 to 13,110.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/techm\/tech-mahindra-ltd-share-price-today\">Tech Mahindra<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,795<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,59,898<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.97<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.49<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,304.10 to 1,854.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Infosys_Return_on_Equity_of_3324\"><\/span><strong>Infosys: Return on Equity of 33.24%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Infosys is a large IT services and consulting company that has built an AI-first offering around its Topaz platform. It reported FY26 revenue of Rs 1,82,972 crore, up 9.83% year on year, and net profit of Rs 29,474 crore, up 10.18%. Net profit has compounded at 7.41% a year since FY22, while revenue has grown 10.23% a year. Operating margin was 25.36% in FY26. The debt-to-equity ratio is 0.10, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 13.56% to Rs 49,195 crore and net profit grew 12.29% to Rs 7,775 crore. Domestic institutions raised their holding from 39.60% in June 2025 to 42.96% in June 2026. The stock trades at a PE of 14.73 against an industry PE of 18.27, below the sector average, with a return on equity of 33.24%. The dividend yield is 4.35%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 34.50 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"UltraTech_Cement_Profit_Compounding_at_336_a_Year\"><\/span><strong>UltraTech Cement: Profit Compounding at 3.36% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>UltraTech Cement is the largest cement producer in India by capacity, with plants and grinding units across the country. It reported FY26 revenue of Rs 89,089.04 crore, up 16.15% year on year, and net profit of Rs 8,188.35 crore, up 35.58%. Revenue has compounded at 13.81% a year since FY22. Operating margin was 19.71% in FY26. The debt-to-equity ratio is 0.31.<\/p>\n<p>In the June 2026 quarter, revenue rose 15.49% to Rs 24,778.47 crore and net profit grew 17.24% to Rs 2,603.72 crore. Domestic institutions raised their holding from 16.65% in September 2025 to 20.86% in September 2026. The stock trades at a PE of 37.70 against an industry PE of 29.41. The dividend yield is 2.19%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Tech_Mahindra_Debt-to-Equity_of_007\"><\/span><strong>Tech Mahindra: Debt-to-Equity of 0.07<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Tech Mahindra, part of the Mahindra Group, provides IT and business services to telecom and other global clients. It reported FY26 revenue of Rs 56,847.30 crore, up 5.58% year on year, and net profit of Rs 4,805.50 crore, up 12.99%. Revenue has compounded at 5.57% a year since FY22. Operating margin was 15.47% in FY26. The debt-to-equity ratio is 0.07, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 30.97 against an industry PE of 18.49, with a return on equity of 16.24%. The dividend yield is 3.12%. In the September 2026 quarter, revenue rose 15.23% to Rs 16,172.80 crore and net profit grew 33.95% to Rs 1,609.70 crore. The share price is up 16.96% over the past year. Domestic institutions raised their holding from 32.13% in June 2025 to 36.92% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_With_PB_Between_3_and_6_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Stocks With PB Between 3 and 6: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these stocks with PB between 3 and 6. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Infosys<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,82,972<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29,474<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.23%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.93%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.52%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">UltraTech Cement<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">89,089.04<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,188.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.81%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.49%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Tech Mahindra<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56,847.30<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,805.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.57%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.23%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.74%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these stocks with PB between 3 and 6<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Infosys_Sun_Pharma_UltraTech_Cement_and_Tech_Mahindra\"><\/span><strong>Institutional Holding in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these stocks with PB between 3 and 6 alongside the promoter. The table uses the latest reported quarter for each. Infosys has the deepest institutional backing, with FII and DII together holding 70.05% as of June 2026. Domestic institutions increased their holding over the past year in Infosys (from 39.60% to 42.96%), Sun Pharma (from 20.23% to 22.27%), UltraTech Cement (from 16.65% to 20.86%) and Tech Mahindra (from 32.13% to 36.92%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Infosys<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.82%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.09%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">UltraTech Cement<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">58.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.86%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Tech Mahindra<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.66%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.92%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.45%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Stocks_With_PB_Between_3_and_6\"><\/span><strong>Risks to Weigh in Stocks With PB Between 3 and 6<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with stocks with PB between 3 and 6 means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Tech Mahindra trades at a PE of 30.97 against an industry PE of 18.49, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Stocks_With_PB_Between_3_and_6\"><\/span><strong>How to Choose Between Stocks With PB Between 3 and 6<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from stocks with PB between 3 and 6 comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (18.27 to 36.42) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among stocks with PB between 3 and 6, Infosys stands out for the highest return on equity at 33.24%, Sun Pharma for the fastest profit growth, 35.75% a year since FY22, UltraTech Cement for 16.15% revenue growth in FY26 and Tech Mahindra for the strongest latest-quarter profit growth at 33.95%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks with PB between 3 and 6 should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Stocks_With_PB_Between_3_and_6_to_Watch\"><\/span><strong>Frequently Asked Questions on Stocks With PB Between 3 and 6 to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_stocks_with_PB_between_3_and_6_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best stocks with PB between 3 and 6 to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra are the 4 names this list highlights, with market caps of Rs 4,46,753 crore, Rs 4,18,102 crore, Rs 3,23,092 crore and Rs 1,59,898 crore respectively. Infosys is notable for the highest return on equity at 33.24%. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. UltraTech Cement offers 16.15% revenue growth in FY26. Tech Mahindra brings the strongest latest-quarter profit growth at 33.95%. These are watchlist names for stocks with PB between 3 and 6, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Infosys_a_good_stock_for_long-term_investors\"><\/span><strong>Is Infosys a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Infosys has a return on equity of 33.24%, a PE of 14.73 against an industry PE of 18.27 and a market cap of Rs 4,46,753 crore. Net profit has compounded at 7.41% a year since FY22, and FY26 revenue rose 9.83% while June 2026 quarter net profit grew 12.29%. Long-term returns in stocks with PB between 3 and 6 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks with PB between 3 and 6 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.50 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Infosys_Sun_Pharma_UltraTech_Cement_and_Tech_Mahindra\"><\/span><strong>What is the market cap of Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 26 October 2026, Infosys has a market cap of Rs 4,46,753 crore, Sun Pharma has a market cap of Rs 4,18,102 crore, UltraTech Cement has a market cap of Rs 3,23,092 crore and Tech Mahindra has a market cap of Rs 1,59,898 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with PB between 3 and 6.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_stocks_with_PB_between_3_and_6\"><\/span><strong>What are the risks of investing in stocks with PB between 3 and 6?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Tech Mahindra trades at a PE of 30.97 against an industry PE of 18.49, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Tech_Mahindra_trading_at_a_PE_of_3097\"><\/span><strong>Why is Tech Mahindra trading at a PE of 30.97?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Tech Mahindra&#8217;s PE of 30.97 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 16.24% and latest-quarter profit growth of 33.95%, which also means the stock is more sensitive if growth slows. Investors in stocks with PB between 3 and 6 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Infosys_Sun_Pharma_UltraTech_Cement_and_Tech_Mahindra\"><\/span><strong>How much do institutions hold in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 70.05% of Infosys (27.09% and 42.96%), 36.63% of Sun Pharma (14.36% and 22.27%), 33.55% of UltraTech Cement (12.69% and 20.86%) and 55.58% of Tech Mahindra (18.66% and 36.92%). Rising institutional holding is a useful signal in stocks with PB between 3 and 6, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best stocks with PB between 3 and 6 to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra are the 4 names this list highlights, with market caps of Rs 4,46,753 crore, Rs 4,18,102 crore, Rs 3,23,092 crore and Rs 1,59,898 crore respectively. Infosys is notable for the highest return on equity at 33.24%. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. UltraTech Cement offers 16.15% revenue growth in FY26. Tech Mahindra brings the strongest latest-quarter profit growth at 33.95%. These are watchlist names for stocks with PB between 3 and 6, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Infosys a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Infosys has a return on equity of 33.24%, a PE of 14.73 against an industry PE of 18.27 and a market cap of Rs 4,46,753 crore. Net profit has compounded at 7.41% a year since FY22, and FY26 revenue rose 9.83% while June 2026 quarter net profit grew 12.29%. Long-term returns in stocks with PB between 3 and 6 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks with PB between 3 and 6 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.50 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 26 October 2026, Infosys has a market cap of Rs 4,46,753 crore, Sun Pharma has a market cap of Rs 4,18,102 crore, UltraTech Cement has a market cap of Rs 3,23,092 crore and Tech Mahindra has a market cap of Rs 1,59,898 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with PB between 3 and 6.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in stocks with PB between 3 and 6?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Tech Mahindra trades at a PE of 30.97 against an industry PE of 18.49, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Tech Mahindra trading at a PE of 30.97?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Tech Mahindra's PE of 30.97 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 16.24% and latest-quarter profit growth of 33.95%, which also means the stock is more sensitive if growth slows. Investors in stocks with PB between 3 and 6 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 70.05% of Infosys (27.09% and 42.96%), 36.63% of Sun Pharma (14.36% and 22.27%), 33.55% of UltraTech Cement (12.69% and 20.86%) and 55.58% of Tech Mahindra (18.66% and 36.92%). Rising institutional holding is a useful signal in stocks with PB between 3 and 6, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap stocks with PB between 3 and 6 compared on market cap, PE, ROE, growth and institutional holding: Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra.<\/p>\n","protected":false},"author":33,"featured_media":327690,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[16393,16394],"class_list":["post-327691","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-stocks-with-pb-between-3-and-6","tag-stocks-with-pb-between-3-and-6-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["327690"],"rank_math_title":["Stocks With PB Between 3 and 6 2026: Infosys, Sun Pharma"],"rank_math_description":["Stocks with PB between 3 and 6 to watch for multibagger potential: Infosys, Sun Pharma, UltraTech Cement and Tech Mahindra. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["stocks with PB between 3 and 6"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-largecap-stocks-with-pb-between-3-and-6-to-watch-for-future-multibagger.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/327691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=327691"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/327691\/revisions"}],"predecessor-version":[{"id":327692,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/327691\/revisions\/327692"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/327690"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=327691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=327691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=327691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}